Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Alcohol-related liver disease and alcoholic hepatitis

Gastroenterology and hepatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Confusion, gastrointestinal bleeding, sepsis, hypotension, acute kidney injury, severe jaundice, hypoglycaemia or dangerous alcohol withdrawal requires hospital assessment. Use the current BSG–BASL decompensated-cirrhosis bundle and local withdrawal pathway, with early hepatology, critical-care and alcohol-care-team involvement.

Synopsis

Detect alcohol-related liver disease without stigma, manage withdrawal and decompensation safely, and recognise severe acute alcohol-related hepatitis requiring specialist treatment.

  • Alcohol-related liver disease spans steatosis, steatohepatitis, fibrosis and cirrhosis; normal aminotransferases do not exclude advanced fibrosis.
  • Ask about alcohol neutrally using beverage type, volume, strength, frequency, alcohol-free days and recent change, then convert to UK units and screen for dependence.
  • A dependent patient can develop seizures or delirium tremens if alcohol stops abruptly; plan monitored withdrawal rather than simply advising immediate unsupported cessation.
  • Acute alcohol-related hepatitis is a clinical syndrome of recent jaundice and systemic inflammation after sustained harmful drinking, not merely an AST higher than ALT.
  • Exclude infection, biliary obstruction, viral hepatitis, drug injury, gastrointestinal bleeding and acute-on-chronic decompensation before attributing jaundice to alcohol-related hepatitis.
  • Obtain a diagnostic ascitic tap promptly in anyone admitted with cirrhosis and ascites, including those without abdominal pain or fever.
  • Nutrition and thiamine are active treatments: assess refeeding risk, provide dietitian-led energy and protein support, and use parenteral thiamine when Wernicke risk or features demand it.
  • Corticosteroids are considered only for specialist-confirmed severe acute alcohol-related hepatitis after contraindications are addressed and benefit is reviewed early with a validated response score.
  • Long-term outcome depends on integrated treatment of both liver disease and alcohol dependence, with relapse-prevention, mental-health, social and transplant pathways offered equitably.

Key red flags

Acute alcohol-related hepatitis

New jaundice over days to weeks with anorexia, fever, tender hepatomegaly, leukocytosis and AST typically exceeding ALT after sustained drinking supports the syndrome once infection and obstruction are excluded.

Decompensated cirrhosis

Ascites, oedema, encephalopathy, variceal bleeding, spontaneous bacterial peritonitis, jaundice or hepatorenal dysfunction marks a major prognostic transition and requires structured acute care.

Alcohol withdrawal

Tremor, sweats, anxiety, nausea, tachycardia, hypertension and insomnia can progress to hallucinations, seizures or delirium tremens, especially with previous complicated withdrawal or high dependence.

Wernicke encephalopathy

Confusion, ataxia or eye-movement abnormality may be incomplete and subtle; malnutrition, vomiting or withdrawal increases risk. Treat suspected disease promptly with parenteral thiamine rather than awaiting imaging.

Infection during severe liver disease

Spontaneous bacterial peritonitis, pneumonia, urinary infection and bacteraemia may present without fever or leukocytosis. New kidney injury, encephalopathy or hypotension may be the only clue.

Alternative acute insult

Very high aminotransferases, severe abdominal pain, shock, paracetamol exposure or biliary dilatation is atypical for alcohol-related hepatitis alone and should redirect the diagnostic work-up.

Investigation priorities

01
Structured alcohol history and AUDIT assessmentFirst step

Quantify exposure, dependence, harms and withdrawal risk without judgement.

Management branches

AdmissionFirst day of decompensated disease

Ascites, encephalopathy, gastrointestinal bleeding, jaundice with organ dysfunction or suspected infection.

  1. Use ABCDE and the current BSG–BASL admission bundle: obtain bloods and cultures, review medicines, assess bleeding and encephalopathy, monitor urine and identify the precipitant.
  2. Perform diagnostic ascitic tap without avoidable delay when ascites is present, start indicated infection or bleeding treatment and involve hepatology early.
  3. Assess alcohol withdrawal and Wernicke risk on arrival; prescribe the local symptom-triggered withdrawal and thiamine regimen with higher-observation care for previous seizures or severe dependence.
  4. Address nutrition, refeeding electrolytes, thrombosis and gastrointestinal prophylaxis individually, and review transplant suitability or ceilings of care rather than assuming alcohol exposure excludes escalation.

Key medicines

Parenteral thiamineUse the local prophylaxis or treatment regimen matched to Wernicke risk.Suspected Wernicke encephalopathy needs prompt high-potency parenteral treatment in a monitored setting. Rare anaphylaxis can occur; emergency glucose for hypoglycaemia must not be delayed.
Symptom-triggered benzodiazepineTitrate through the authorised withdrawal scale and local liver-impairment protocol.Hepatic encephalopathy, sepsis and head injury can mimic withdrawal. Oversedation and respiratory depression are dangerous; severe liver dysfunction affects agent choice and requires experienced review.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • BSG BASL alcohol-related liver disease standardsRecognition, acute hepatitis, decompensation and continuing care.
  • NICE CG100 alcohol physical complicationsWithdrawal, Wernicke encephalopathy and alcohol-related hepatitis treatment.
  • BSG BASL decompensated cirrhosis bundleFirst 24-hour admission management.
  • BSG UK alcohol-related transplant referralEquitable specialist referral principles.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom